Show simple item record

dc.contributor.authorO'Sullivan, Jacinthaen
dc.contributor.authorReynolds, Johnen
dc.contributor.authorMc Manus, Rossen
dc.date.accessioned2015-03-04T14:52:37Z
dc.date.available2015-03-04T14:52:37Z
dc.date.issued2015en
dc.date.submitted2015en
dc.identifier.citationPalles C, Chegwidden L, Li X, Findlay JM, Farnham G, Castro Giner F, Peppelenbosch MP, Kovac M, Adams CL, Prenen H, Briggs S, Harrison R, Sanders S, MacDonald D, Haigh C, Tucker A, Love S, Nanji M, deCaestecker J, Ferry D, Rathbone B, Hapeshi J, Barr H, Moayyedi P, Watson P, Zietek B, Maroo N, Gay L, Underwood T, Boulter L, McMurtry H, Monk D, Patel P, Ragunath K, Al Dulaimi D, Murray I, Koss K, Veitch A, Trudgill N, Nwokolo C, Rembacken B, Atherfold P, Green E, Ang Y, Kuipers EJ, Chow W, Paterson S, Kadri S, Beales I, Grimley C, Mullins P, Beckett C, Farrant M, Dixon A, Kelly S, Johnson M, Wajed S, Dhar A, Sawyer E, Roylance R, Onstad L, Gammon MD, Corley DA, Shaheen NJ, Bird NC, Hardie LJ, Reid BJ, Ye W, Liu G, Romero Y, Bernstein L, Wu AH, Casson AG, Fitzgerald R, Whiteman DC, Risch HA, Levine DM, Vaughan TL, Verhaar AP, van den Brande J, Toxopeus EL, Spaander MC, Wijnhoven BP, van der Laan LJ, Krishnadath K, Wijmenga C, Trynka G, McManus R, Reynolds JV, O'Sullivan J, MacMathuna P, McGarrigle SA, Kelleher D, Vermeire S, Cleynen I, Bisschops R, Tomlinson I, Jankowski J, Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett's Esophagus., Gastroenterology, 148, 2, 2015, 367-78en
dc.identifier.issn0016-5085en
dc.identifier.otherYen
dc.descriptionPUBLISHEDen
dc.description.abstractBarrett ’ s esophagus (BE) increases the risk of esophageal adenocarcinoma (EAC). We found the risk to be BE has been associated with single nucleotide polymorphisms (SNPs) on chromosome 6p21 (within the HLA region) and on 16q23, where the closest protein-coding gene is FOXF1 .Subse- quently, the Barrett ’ s and Esophageal Adenocarcinoma Con- sortium (BEACON) identi fi ed risk loci for BE and esophageal adenocarcinoma near CRTC1 and BARX1 , and within 100 kb of FOXP1 . We aimed to identify further SNPs that increased BE risk and to validate previously reported associations. METHODS: We performed a genome-wide association study (GWAS) to identify variants associated with BE and further analyzed promising variants identi fi ed by BEACON by genotyping 10,158 patients with BE and 21,062 controls. RESULTS: Weidenti fi ed2SNPsnot previouslyassociated with BE: rs3072 (2p24.1; oddsratio [OR] ¼ 1.14; 95% CI: 1.09 – 1.18; P ¼ 1.8 10 11 ) and rs2701108 (12q24.21; OR ¼ 0.90; 95% CI: 0.86 – 0.93; P ¼ 7.5 10 9 ). The closest protein-coding genes were respectively GDF7 (rs3072), which encodes a ligand in the bone morphogenetic protein pathway, and TBX5 (rs2701108), which encodes a transcription factor that regulates esophageal and cardiac development. Our dataalsosupported inBEcases3 riskSNPsidenti fi edbyBEACON (rs2687201, rs11789015, and rs10423674). Meta-analysis of all data identi fi ed another SNP associated with BE and esophageal adenocarcinoma: rs3784262, within ALDH1A2 (OR ¼ 0.90; 95% CI: 0.87 – 0.93; P ¼ 3.72 10 9 ). CONCLUSIONS: We identi fi ed 2 loci associated with risk of BE and provided data to support a further locus. The genes we found to be associated with risk for BE encode transcription factors involved in thoracic, diaphrag- matic, and esophageal development or proteins involved in the in fl ammatory responseen
dc.description.sponsorshipThe authors would like to thank the WTCCC2 consortium, the BEACON consortium and the AspECT, BOSS, and ChOPIN trial teams (comprising the EAGLE consortium) and participants in all these studies. The Discovery Phase and Immunochip replication were funded by the Wellcome Trust IPOD grant (084722/Z/08/Z). In addition, sample collection for all phases was core supported by the Cancer Research UK funded AspECT, ChOPIN and Handel trials. CoRGI and GLACIER were also funded by Cancer Research UK. In addition, the authors thank AstraZeneca for an educational grant for the tissue and blood collection. Core funding to the Wellcome Trust Centre for Human Genetics was provided by the Wellcome Trust (090532/Z/09/Z). We also thank Liam J. Murray and Wong-Ho Chow, who provided samples as part of the BEACON consortium. The authors would also like to thank the Experimental Cancer Medicine Centre–supported University of Southampton Faculty of Medicine Tissue Bank. The Cancer Genome Atlas (TCGA) esophageal carcinoma data were also gratefully used for expression analyses. Finally, the authors want to thank Dr Vincent Plagnol of University College London for advice on statistical analyses and presentation.en
dc.format.extent367-78en
dc.language.isoenen
dc.relation.ispartofseriesGastroenterologyen
dc.relation.ispartofseries148en
dc.relation.ispartofseries2en
dc.rightsYen
dc.subjectEAC, Intestinal Metaplasia, Susceptibility, Canceren
dc.subject.lcshEAC, Intestinal Metaplasia, Susceptibility, Canceren
dc.titlePolymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett's Esophagus.en
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/reynoljven
dc.identifier.peoplefinderurlhttp://people.tcd.ie/osullij4en
dc.identifier.peoplefinderurlhttp://people.tcd.ie/rmcmanusen
dc.identifier.rssinternalid100419en
dc.identifier.doihttp://dx.doi.org/10.1053/j.gastro.2014.10.041en
dc.rights.ecaccessrightsopenAccess
dc.subject.TCDThemeGenes & Societyen
dc.subject.TCDThemeImmunology, Inflammation & Infectionen
dc.subject.TCDThemeInternational Developmenten
dc.identifier.urihttp://hdl.handle.net/2262/73414


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record